A new research program spearheaded by Heroic Hearts Project is investigating the potential therapeutic effects of psilocybin on veterans with Traumatic Brain Injury (TBI).
Mental Health
A new paper explores the intersection of mysticism and psychedelic research and highlights the need for cultural sensitivity and inclusive exploration of psychedelic-induced mystical experiences
Consciousness
MindMed announces positive results in phase 2 trial of LSD therapy for Major Depressive Disorder.
Explore the potential of using psilocybin, derived from “magic mushrooms,” to enhance the quality of life for patients with life-threatening illnesses.
End of Life
Discover how microdoses of LSD can influence our sense of time.
Looking to learn more about ibogaine? Here’s everything you need to know about this plant-based psychedelic, including its history, safety profile, potential therapeutic uses, and more.
Addiction
New study explores the potential of psilocybin for treating major depressive disorder
Despite the promising results of psychedelic trials, the issue of selection bias can skew study outcomes and prevent us from understanding their true potential.
Science
Discover the world's first pilot study of extended-state DMT.
A new study on the effects of microdosing LSD in healthy volunteers finds short-term mood-boosting effects but no significant long-term benefits.
Biohacking
Oregon has taken a groundbreaking step by licensing its first legal psilocybin mushroom growers and facilitators, paving the way for the therapeutic use of psilocybin in the state.
Small Pharma has reported positive results from a Phase IIa clinical trial of SPL026, a pharmaceutical-grade formulation of DMT, in treating Major Depressive Disorder.
.png)
